ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Anti-Gram-negative beta-lactams in jeopardy: The rise of PBP3 mutations
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
Mirror Bacteria: An AMR threat of unprecedented magnitude
FDA analysis of 40-years of antibacterial development: Dheman et al.
FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet